A NOVEL T CELL ACTIVATION CONTROLLED BY A DISEASE GENE
由疾病基因控制的新型 T 细胞激活
基本信息
- 批准号:6700242
- 负责人:
- 金额:$ 32.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-01-01 至 2005-12-31
- 项目状态:已结题
- 来源:
- 关键词:T cell receptorT lymphocyteantigen receptorsautoantigenscyclin dependent kinasecytokine receptorsdiabetes mellitus geneticsdisease /disorder modelenzyme inhibitorsgenetic susceptibilityimmunogeneticsinsulin dependent diabetes mellitusinterleukin 2laboratory ratleukocyte activation /transformationlymphopeniamitogen activated protein kinaseproliferating cell nuclear antigenretinoblastoma protein
项目摘要
DESCRIPTION: (Adapted from the Investigator's abstract): The development of
diabetes spontaneously in the BB rat requires a diabetogenic gene termed lyp.
Lyp is named after the phenotype it creates, peripheral T cell lymphopenia.
Most T cells from lymphopenic animals have a dramatically shortened life span
and when they fail to become members of the long lived peripheral T cell pool
the lymphopenic environment is created. A major focus of our work has been
directed to understanding how the lyp gene and the resultant lymphopenia
contribute to disease. Our recent observations indicate that most T cells from
diabetes-prone BB animals express a novel activation state, defined by a
quiescent cell surface but activated internal measures of cell cycle machinery.
We believe this novel activation state is the impetus through which
autoreactive T cells become activated. In this application we will test several
hypotheses formulated from our data. First, the cause of the lymphopenia is the
lyp gene mediated cell cycle arrest of T cells as they attempt to progress from
G1 to S phase. Second, lymphopenia creates space in the periphery. Space
provides clonal expansion signals for recent thymic emigrants that bear T cell
receptors for self antigens. Third, autoreactive T cells can overcome the lyp
gene mediated cell cycle arrest because they express high affinity receptors
for self antigens. If our hypotheses are correct, as tested in the experiments
proposed in this application, the data generated will permit us to understand
how at least one genetic susceptibility region contributes to disease in this
rat model.
描述:(改编自《调查员摘要》):
BB大鼠的自发性糖尿病需要一种名为LYP的糖尿病基因。
LYP是根据它产生的表型--外周T细胞淋巴细胞减少症而命名的。
大多数来自淋巴细胞减少动物的T细胞寿命显著缩短
当它们不能成为长寿外周T细胞池的成员时
创造了淋巴细胞减少的环境。我们工作的一个主要重点是
旨在了解LYP基因和由此导致的淋巴细胞减少症
会导致疾病。我们最近的观察表明,大多数来自
易患糖尿病的BB动物表达一种新的激活状态,由一种
细胞表面静止,但激活了细胞周期机制的内部测量。
我们认为,这种新的激活状态是通过
自体反应性T细胞被激活。在此应用程序中,我们将测试几个
根据我们的数据提出的假设。首先,淋巴细胞减少的原因是
LYP基因介导的T细胞细胞周期停滞
G1期至S期。其次,淋巴细胞减少症在外围创造了空间。空间
为携带T细胞的近期胸腺移居者提供克隆性扩增信号
自身抗原的受体。第三,自身反应性T细胞可以克服LYP
基因介导的细胞周期停滞因为它们表达高亲和力受体
用于自身抗原。如果我们的假设是正确的,就像在实验中测试的那样
在本申请中提出的,生成的数据将使我们能够理解
至少一个遗传易感区域是如何导致这一地区疾病的
大鼠模型。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DONALD BELLGRAU其他文献
DONALD BELLGRAU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DONALD BELLGRAU', 18)}}的其他基金
Provoking anti-tumor immune responses with Fas ligand
通过 Fas 配体激发抗肿瘤免疫反应
- 批准号:
7291653 - 财政年份:2006
- 资助金额:
$ 32.28万 - 项目类别:
Provoking anti-tumor immune responses with Fas ligand
通过 Fas 配体激发抗肿瘤免疫反应
- 批准号:
7161959 - 财政年份:2006
- 资助金额:
$ 32.28万 - 项目类别:
A NOVEL T CELL ACTIVATION CONTROLLED BY A DISEASE GENE
由疾病基因控制的新型 T 细胞激活
- 批准号:
6229942 - 财政年份:2001
- 资助金额:
$ 32.28万 - 项目类别:
A NOVEL T CELL ACTIVATION CONTROLLED BY A DISEASE GENE
由疾病基因控制的新型 T 细胞激活
- 批准号:
6489752 - 财政年份:2001
- 资助金额:
$ 32.28万 - 项目类别:
A NOVEL T CELL ACTIVATION CONTROLLED BY A DISEASE GENE
由疾病基因控制的新型 T 细胞激活
- 批准号:
6626996 - 财政年份:2001
- 资助金额:
$ 32.28万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 32.28万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 32.28万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 32.28万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 32.28万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 32.28万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 32.28万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 32.28万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 32.28万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 32.28万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 32.28万 - 项目类别:
Discovery Grants Program - Individual